Cargando…
Genetically Modified Mesenchymal Stem Cells: The Next Generation of Stem Cell-Based Therapy for TBI
Mesenchymal stem cells (MSCs) are emerging as an attractive approach for restorative medicine in central nervous system (CNS) diseases and injuries, such as traumatic brain injury (TBI), due to their relatively easy derivation and therapeutic effect following transplantation. However, the long-term...
Autores principales: | Shahror, Rami Ahmad, Wu, Chung-Che, Chiang, Yung-Hsiao, Chen, Kai-Yun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312789/ https://www.ncbi.nlm.nih.gov/pubmed/32516998 http://dx.doi.org/10.3390/ijms21114051 |
Ejemplares similares
-
Enhanced Homing of Mesenchymal Stem Cells Overexpressing Fibroblast Growth Factor 21 to Injury Site in a Mouse Model of Traumatic Brain Injury
por: Shahror, Rami Ahmad, et al.
Publicado: (2019) -
Efficient Labeling Of Mesenchymal Stem Cells For High Sensitivity Long-Term MRI Monitoring In Live Mice Brains
por: Ali, Ahmed Atef Ahmed, et al.
Publicado: (2020) -
Mesenchymal Stem/Stromal Cell Therapy in Blood–Brain Barrier Preservation Following Ischemia: Molecular Mechanisms and Prospects
por: Do, Phuong Thao, et al.
Publicado: (2021) -
Human adipose-derived mesenchymal stem cells for acute and sub-acute TBI
por: Ruppert, Katherine A., et al.
Publicado: (2020) -
Correction: Human adipose-derived mesenchymal stem cells for acute and sub-acute TBI
por: Ruppert, Katherine A., et al.
Publicado: (2021)